Dali Pharmaceuticalco.,Ltd (603963.SS) SHH
1.18
+0(+0.00%)
Currency In CNY
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 2.64B |
| Enterprise Value | 2.65B |
| P/E Ratio | -13.11 |
| PEG Ratio | 0.96 |
| Price/Sales Ratio | 2.97 |
| Price/Book Ratio | 0.69 |
| Enterprise/Revenue | 3.08 |
| Enterprise/EBITDA | 778.77 |
Fiscal Year
| Fiscal Year | December 31, 2023 |
| Most Recent Quarter | September 30, 2024 |
Profitability
| Profit Margin | -0.23 |
| Operating Margin | -0.2 |
Management Effectiveness
| Return On Assets | -0.04 |
| Return On Equity | -0.05 |
Income Statement
| Revenue | 87.27M |
| Revenue/Share | 0.39 |
| Gross Profit | 36.3M |
| EBITDA | 345,051.27 |
| Net Income | -20.03M |
| Diluted EPS | -0.09 |
Balance Sheet
| Total Cash | 207.69M |
| Total Cash/Share | 0.99 |
| Total Debt | 11.01M |
| Total Debt/Equity | 0.06 |
| Current Ratio | 3.76 |
| Book Value Per Share | 1.71 |
Price History
| 52-Week Change | -84.16 |
| 52-Week High | 15.97 |
| 52-Week Low | 1.18 |
| Moving Average 50 Days | 1.57 |
| Moving Average 200 Days | 2.74 |
Statistics
| Average Volume | 3.55M |
| Shares Outstanding | 219.7M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | -0.08 |
| Last Split Factor | 13:10 |
| Last Split Date | June 08, 2020 |
